/* Popup Styles */

Call for Abstracts

  • Coronavirus (COVID-19) & Pandemic Vaccines
  • COVID-19 Vaccine Research
  • Vaccine Research and Development
  • mRNA Vaccines
  • DNA and RNA Vaccines
  • Viral Vector Vaccines
  • Recombinant Vaccines
  • Personalized Vaccines
  • Next-Generation Vaccines: Advancements and Challenges
  • Thermo-Stabilized Vaccines
  • Influenza and Respiratory Vaccines
  • Conjugate Vaccines
  • Cancer Vaccines and Immunotherapy
  • Paediatric Vaccines & Immunology
  • Veterinary Vaccines
  • Vaccines for Neglected Diseases
  • Parasitic and Fungal Vaccines
  • Fungal/Bacterial/Viral/Parasitic/STD Vaccines
  • Vaccine Adjuvants
  • Safety and Efficacy of Vaccines
  • Clinical Trials on Vaccines
  • Vaccine Production, Supply & Logistics
  • Bioprocessing and Manufacturing
  • Vaccine-Pathogen Interaction
  • Immunogenetics
  • Immunopathology
  • Viral Immunology
  • Immunization in Special Groups
  • Vaccine Hesitancy
  • Global Vaccination Programs
  • Emerging and Re-Emerging Diseases
  • Epidemiology and Public Health
  • Antimicrobial Resistance (AMR)
  • AI Approaches in Vaccine Development
  • Human Vaccines & Immunotherapeutics
Contact

+1 281-968-3414

+1 707-314-6422

» Contact Us
Address

Times Scientific Group
25505 W Cerena Cir
Plainfield, IL 60586, USA

Email Us

[email protected]
[email protected]

+1 (707) 378-6010